Acrobat Genomics, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine to Discover New Drug Targets for Gene Editing-Based Therapeutics
Acrobat Genomics, NanoString Technologies, Inc. , and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based... | June 8, 2023
Brad Gray Nick Hughes Nanostring Geomx Tushar Desai Illumina Accelerator Program Nanostring Technologies Inc
Source: marketscreener.com